Trials of Edmonston-Zagreb measles vaccine in Guinea-Bissau: serological responses following vaccination with Edmonston-Zagreb strain at 4–8 months versus vaccination with Schwarz strain at 9–12 months of age
- 1 January 1994
- Vol. 12 (11), 1026-1031
- https://doi.org/10.1016/0264-410x(94)90340-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: Increased female mortality rateThe Journal of Pediatrics, 1993
- The 1st International Standard for anti-measles serumBiologicals, 1991
- Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccineThe Pediatric Infectious Disease Journal, 1991
- Measles Incidence, Vaccine Efficacy, and Mortality in Two Urban African Areas with High Vaccination CoverageThe Journal of Infectious Diseases, 1990
- Immunization of Six-Month-Old Infants with Different Doses of Edmonston–Zagreb and Schwarz Measles VaccinesNew England Journal of Medicine, 1990
- SEROLOGICAL EFFECTS OF EDMONSTON-ZAGREB, SCHWARZ, AND AIK-C MEASLES VACCINE STRAINS GIVEN AT AGES 4-5 OR 8-10 MONTHSThe Lancet, 1989
- EFFECTS OF DOSE AND STRAIN OF VACCINE ON SUCCESS OF MEASLES VACCINATION OF INFANTS AGED 4-5 MONTHSThe Lancet, 1988
- COMPARISON OF EDMONSTON-ZAGREB AND SCHWARZ STRAINS OF MEASLES VACCINE GIVEN BY AEROSOL OR SUBCUTANEOUS INJECTIONThe Lancet, 1987
- Long-term antibody response after measles vaccination in an isolated arctic society in GreenlandVaccine, 1986
- High measles mortality in infancy related to intensity of exposureThe Journal of Pediatrics, 1986